Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
CXCR4 and cancer.
Furusato B, Mohamed A, Uhlén M, Rhim JS. Furusato B, et al. Pathol Int. 2010 Jul;60(7):497-505. doi: 10.1111/j.1440-1827.2010.02548.x. Pathol Int. 2010. PMID: 20594270 Review.
Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer.
Furusato B, Gao CL, Ravindranath L, Chen Y, Cullen J, McLeod DG, Dobi A, Srivastava S, Petrovics G, Sesterhenn IA. Furusato B, et al. Mod Pathol. 2008 Feb;21(2):67-75. doi: 10.1038/modpathol.3800981. Epub 2007 Dec 7. Mod Pathol. 2008. PMID: 18065961
Osteoblast-specific factor 2 expression in prostate cancer-associated stroma: identification through microarray technology.
Furusato B, Tsunoda T, Shaheduzzaman S, Nau ME, Vahey M, Petrovics G, McLeod DG, Naito S, Shirasawa S, Srivastava S, Sesterhenn IA. Furusato B, et al. Urology. 2010 Apr;75(4):768-72. doi: 10.1016/j.urology.2009.10.026. Epub 2009 Dec 29. Urology. 2010. PMID: 20035976
Evaluation of ERG responsive proteome in prostate cancer.
Tan SH, Furusato B, Fang X, He F, Mohamed AA, Griner NB, Sood K, Saxena S, Katta S, Young D, Chen Y, Sreenath T, Petrovics G, Dobi A, McLeod DG, Sesterhenn IA, Saxena S, Srivastava S. Tan SH, et al. Prostate. 2014 Jan;74(1):70-89. doi: 10.1002/pros.22731. Epub 2013 Sep 21. Prostate. 2014. PMID: 24115221 Free PMC article.
Delineation of TMPRSS2-ERG splice variants in prostate cancer.
Hu Y, Dobi A, Sreenath T, Cook C, Tadase AY, Ravindranath L, Cullen J, Furusato B, Chen Y, Thangapazham RL, Mohamed A, Sun C, Sesterhenn IA, McLeod DG, Petrovics G, Srivastava S. Hu Y, et al. Clin Cancer Res. 2008 Aug 1;14(15):4719-25. doi: 10.1158/1078-0432.CCR-08-0531. Clin Cancer Res. 2008. PMID: 18676740
Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.
Rosner IL, Ravindranath L, Furusato B, Chen Y, Gao C, Cullen J, Sesterhenn IA, McLeod DG, Srivastava S, Petrovics G. Rosner IL, et al. Urology. 2007 Dec;70(6):1225-9. doi: 10.1016/j.urology.2007.09.010. Urology. 2007. PMID: 18158066
Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells.
Li H, Zhou J, Miki J, Furusato B, Gu Y, Srivastava S, McLeod DG, Vogel JC, Rhim JS. Li H, et al. Exp Cell Res. 2008 Jan 1;314(1):92-102. doi: 10.1016/j.yexcr.2007.08.011. Epub 2007 Aug 23. Exp Cell Res. 2008. PMID: 17900565
Silencing of Lactotransferrin expression by methylation in prostate cancer progression.
Shaheduzzaman S, Vishwanath A, Furusato B, Cullen J, Chen Y, Bañez L, Nau M, Ravindranath L, Kim KH, Mohammed A, Chen Y, Ehrich M, Srikantan V, Sesterhenn IA, McLeod D, Vahey M, Petrovics G, Dobi A, Srivastava S. Shaheduzzaman S, et al. Cancer Biol Ther. 2007 Jul;6(7):1088-95. doi: 10.4161/cbt.6.7.4327. Cancer Biol Ther. 2007. PMID: 17568188
Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
Miki J, Furusato B, Li H, Gu Y, Takahashi H, Egawa S, Sesterhenn IA, McLeod DG, Srivastava S, Rhim JS. Miki J, et al. Cancer Res. 2007 Apr 1;67(7):3153-61. doi: 10.1158/0008-5472.CAN-06-4429. Cancer Res. 2007. PMID: 17409422
69 results
Jump to page